Suchergebnisse - "Burmester, Gerd R"

PubPharm (610)

1

Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs : Efficacy and Safety Through 5 Years (SELECT-NEXT)

enthalten in: The Journal of rheumatology | 2024

von Burmester, G. | Van den Bosch, F. | Tesser, J. | +5

2

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update

enthalten in: Annals of the rheumatic diseases | 2024

von Gossec, L. | Kerschbaumer, A. | Ferreira, R. | +33

3

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA) : a randomised, international, multicentre, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2024

von Rech, J. | Tascilar, K. | Hagen, M. | +31

4

Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases : Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials

enthalten in: Advances in therapy | 2024

von Mysler, E. | Burmester, G. | Saffore, C. | +7

5

Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis : What Have We Learned?

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024

von Avci, A. | Feist, E. | Burmester, G.

6

Correction : Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

enthalten in: Rheumatology and therapy | 2024

von Burmester, G. | Coates, L. | Cohen, S. | +8

ErratumFor: Rheumatol Ther. 2023 Oct;10(5):1255-1276. - PMID 37458964

7

Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA : Integrated Data Up to 6.5 Years

enthalten in: Rheumatology and therapy | 2024

von Charles-Schoeman, C. | Giles, J. | Lane, N. | +11

8

Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years

enthalten in: Rheumatology and therapy | 2024

von Charles-Schoeman, C. | Giles, J. | Lane, N. | +11

9

Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials

enthalten in: Advances in therapy | 2024

von Mysler, E. | Burmester, G. | Saffore, C. | +7

10

Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases : The ERN-ReCONNET VACCINATE study

enthalten in: Journal of translational autoimmunity | 2023

von Tani, C. | Cardelli, C. | Depascale, R. | +40

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[61]